-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Connect Biopharma Hldgs, Lowers Price Target to $5

Benzinga·09/30/2026 16:54:17
Listen to the news
BTIG analyst Julian Harrison maintains Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and lowers the price target from $10 to $5.